Pharmaceutical

X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition

Pivotal Phase 3 4WARD clinical trial is evaluating use of oral mavorixafor as monotherapy and in combination with injectable G-CSFBOSTON,…

3 weeks ago

Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of…

3 weeks ago

BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

3 weeks ago

Ensysce Biosciences Announces 1-for-15 Reverse Stock Split

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage…

3 weeks ago

75% of Hospitals Face Medication Shortages – Germfree and On Demand Pharmaceuticals Partner to Deliver Localized Production Solutions

Partners working to expand program after successful six-month pilot study at North Mississippi Medical Center, which enabled production of 12,000…

3 weeks ago

Drug-Pricing Expert Katheryne Richardson Joins BRG’s Healthcare Practice as Managing Director

Richardson brings 25+ years of experience navigating complex drug-pricing and access challenges WASHINGTON, Dec. 3, 2024 /PRNewswire/ -- Global expert…

3 weeks ago

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth WEXFORD, Pa. ,…

3 weeks ago

STEVENSON SEARCH PARTNERS ANNOUNCES NEW LEADERSHIP AND EXPANDED SERVICES

Long-standing, global firm innovates with new on-demand talent solutions, executive coaching, and board advisory as part of new strategic transition…

3 weeks ago

Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

WOBURN, MA / ACCESSWIRE / December 3, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing…

3 weeks ago